ArticleTechnology in cancer research & treatment2019

Integrated Analysis of Transcriptome and Prognosis Data Identifies FGF22 as a Prognostic Marker of Lung Adenocarcinoma.

Hong-Yan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.